Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis
Crossref DOI link: https://doi.org/10.1007/s12325-019-00981-y
Published Online: 2019-05-16
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bassetti, Matteo
Giacobbe, Daniele Roberto
Patel, Niki
Tillotson, Glenn
Massey, Jill
Funding for this research was provided by:
The Medicines Company (1)
Text and Data Mining valid from 2019-05-16
Version of Record valid from 2019-05-16
Article History
Received: 6 March 2019
First Online: 16 May 2019